TICKERNOMICS Sign up
Last Update: 2024-12-27 15:25:08
AVANOS MEDICAL INC. ( AVNS ) https://avanos.com
16.16USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-28.97%
AVNS
SPY
32.66%
-52.71%
AVNS
SPY
108.59%
-51.85%
AVNS
SPY
302.52%
-63.78%
AVNS
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
744.50
871.40
0.25
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
47.42
1.09
0.61
3.33
0.00
12.89
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
7.04
54.52
9.96
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
8.1104
1.35
2.25
1.03
Other Earnings and Cash Flow Stats:
AVANOS MEDICAL INC. ( AVNS ) Net Income TTM ($MM) is 15.70
AVANOS MEDICAL INC. ( AVNS ) Operating Income TTM ($MM) is 44.50
AVANOS MEDICAL INC. ( AVNS ) Owners' Earnings Annual ($MM) is 20.68
AVANOS MEDICAL INC. ( AVNS ) Current Price to Owners' Earnings ratio is 50.76
AVANOS MEDICAL INC. ( AVNS ) EBITDA TTM ($MM) is 84.00
AVANOS MEDICAL INC. ( AVNS ) EBITDA Margin is 9.96%
Capital Allocation:
AVANOS MEDICAL INC. ( AVNS ) has paid 0.00 dividends per share and bought back 0.5 million shares in the past 12 months
AVANOS MEDICAL INC. ( AVNS ) has reduced its debt by 103.5 million USD in the last 12 months
Capital Structure:
AVANOS MEDICAL INC. ( AVNS ) Interest-bearing Debt ($MM) as of last quarter is 215
AVANOS MEDICAL INC. ( AVNS ) Annual Working Capital Investments ($MM) are -8
AVANOS MEDICAL INC. ( AVNS ) Book Value ($MM) as of last quarter is 1229
AVANOS MEDICAL INC. ( AVNS ) Debt/Capital as of last quarter is 17%
Other Balance Sheet Stats:
AVANOS MEDICAL INC. ( AVNS ) has 89 million in cash on hand as of last quarter
AVANOS MEDICAL INC. ( AVNS ) has 212 million of liabilities due within 12 months, and long term debt 162 as of last quarter
AVANOS MEDICAL INC. ( AVNS ) has 46 common shares outstanding as of last quarter
AVANOS MEDICAL INC. ( AVNS ) has 0 million USD of preferred stock value
Academic Scores:
AVANOS MEDICAL INC. ( AVNS ) Altman Z-Score is 1.45 as of last quarter
AVANOS MEDICAL INC. ( AVNS ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
AVANOS MEDICAL INC. ( AVNS ) largest shareholder is owning shares at 0.00 ($MM) value
Greiner Michael(an insider) Sold 110 shares of AVANOS MEDICAL INC. ( AVNS ) for the amount of $2107.60 on 2024-03-14
2.95% of AVANOS MEDICAL INC. ( AVNS ) is held by insiders, and 94.40% is held by institutions
AVANOS MEDICAL INC. ( AVNS ) went public on 2014-10-21
Other AVANOS MEDICAL INC. ( AVNS ) financial metrics:
FCF:36.60
Unlevered Free Cash Flow:90.90
EPS:0.37
Operating Margin:7.04
Gross Profit Margin:54.52
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:1.40
Beta:1.03
Buffet's Owners Earnings:20.68
Price to Owner's Earnings:50.76
About AVANOS MEDICAL INC. ( AVNS ) :
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy and OrthogenRx's knee osteoarthritis pain relief injection products. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.